Company Overview
Snapshot
Founded in August 2012 by Tuvia Elbaum, Yitzi Kempinski, and Nir Blushtein, Umoove operates with 1–10 employees. The company has raised $2.75 million across four funding rounds from two investors.
Business overview
Umoove develops face and eye tracking software designed for mobile devices, eliminating the need for additional hardware. Its core technology enables devices to interpret face and eye movements, providing an interactive language and valuable data. The company's solutions are applicable across various markets, including gaming, advertising, sports, and wearable AR/VR, with a significant focus on healthcare for analyzing brain activity related to conditions like ADHD, concussions, strokes, autism, and Parkinson’s disease. Umoove operates within the Health Tech & Life Sciences sector, specifically in Digital Healthcare and Digital Medical Diagnostics, leveraging AI, computer vision, and software platforms.
Strategic signal
In May 2021, Umoove launched an app focused on tackling mental health challenges, leveraging its eye-tracking technology. This development signals the company's strategic expansion beyond its core technology licensing into direct-to-consumer applications, particularly within the digital health and wellness market. It demonstrates a proactive approach to applying its patented technology to address pressing societal needs, potentially opening new revenue streams and validating the broader utility of its face and eye-tracking capabilities for health-related applications.
Log in to access full profile ›Company Intelligence Q&A
- What is Umoove's primary technology?
- Umoove specializes in face and eye-tracking software that operates on mobile devices without requiring additional hardware. This technology utilizes unique algorithms and computer vision to interpret user gaze and facial movements.
- When was Umoove founded and by whom?
- Umoove was founded in August 2012 by Tuvia Elbaum, Yitzi Kempinski, and Nir Blushtein.
- How does Umoove's technology contribute to healthcare?
- Umoove's eye-tracking technology provides a window into analyzing brain activity, which can aid in observing conditions such as ADHD, concussions, strokes, autism, and Parkinson’s disease. The company has also developed an app to tackle mental health challenges, launched in May 2021.
- What is the patent status of Umoove's technology?
- Umoove's technology is built on unique algorithms, and the company has more than 15 patents pending.